Mild Cognitive Impairment in Parkinson's Disease

NCT01519271 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease
Mild Cognitive Impairment

Interventions

DRUG: Exelon Patch (rivastigmine transdermal system)
DRUG: Placebo Patches

Sponsor

University of Pennsylvania